Adoption of technology has a life cycle that typically follows a bell-shaped curve. There are early adopters,
As the Bioanalytical support for drug development continues to grow, more and more scientists are requiring more complex assays.
The FDA has not approved marijuana for any indication, as it continues to retain Schedule I designation.
The FDA has regulated cigarettes, smokeless and loose tobacco since 2009 under the Tobacco Control Act.
Immuno-oncology is a growing field. The goal is to augment the patient’s immune system to attack the cancer cells.
Once again we find ourselves wrapping up our 2017 goals and and tallying the year’s performance.